Novartis
Novartis is a multinational pharmaceutical company that was founded in 1996 with a vision to advance science to improve human health around the world. As a global leader in healthcare, the company offers innovative, high-quality products and services across ranging from prescription medicines and over-the-counter products, to generics and biosimilars, eye care, and animal health. With over 120,000 associates in more than 140 countries, Novartis' presence translates into direct access to the world's most advanced medical research and resources.
In order to meet the highest standards of patient care and safety, Novartis creates and manufactures high-quality, innovative pharmaceuticals, generics, and biosimilars. Their CERILLIANT® line, for instance, comprises solutions ranging from 3 forms inner standards to generic peptides, enabling accurate, qualitative, and quantitative reference standards. Furthermore, Novartis also invests heavily in research and development, specifically in the creation of novel medicines for patients in areas of unmet medical need.
Novartis' target audience encompasses all demographics, ranging from medical professionals and academics, to global healthcare organizations and patients. The company offers a unique combination of resources and products to fit the ever evolving needs of all of its customers. Novartis is passionate about playing a key role in global healthcare innovation, providing access to their advanced technologies according to customer's needs.